Yamamoto Shuichi

Fujinami Kaoru, Akiyama Kunihiko, Tsunoda Kazushige, Ito Saori, Seko Noriko, Yamamoto Shuichi

Voretigene neparvovec gene therapy improved light sensitivity and visual fields in Japanese RPE65-retinopathy patients over one year, with a good safety profile, supporting its broader clinical use.

Baba Takayuki, Kawasaki Ryo, Yamakiri Keita, Koto Takashi, Nishitsuka Koichi, Yamamoto Shuichi et al.

This study found that for rhegmatogenous retinal detachment, pars plana vitrectomy and scleral buckling yield comparable visual outcomes if concurrent cataract surgery is excluded, guiding surgical choice.

Tatsumi Tomoaki, Yamamoto Shuichi, Uehara Juntaro, Sugawara Takeshi, Baba Takayuki, Inoue Masayuki et al.

This study found combining panretinal photocoagulation (PRP), intravitreal bevacizumab (IVB), and cryoretinopexy significantly improved intraocular pressure control in neovascular glaucoma compared to PRP+IVB alone, enhancing treatment effectiveness.

Baba Takayuki, Hagiwara Akira, Sato Eiju, Arai Miyuki, Oshitari Toshiyuki, Yamamoto Shuichi

This study compared BBG and ICG for macular hole surgery, finding BBG resulted in better visual acuity and retinal sensitivity. Clinically, BBG may be a superior staining agent.

Baba Takayuki, Hagiwara Akira, Yamamoto Shuichi

Yamamoto Shuichi, Takatsuna Yoko, Sato Eiju, Mizunoya Satoshi

Radial optic neurotomy for CRVO caused central retinal artery occlusion and permanent blindness. This highlights severe risks of this unproven procedure, cautioning against its use.